Immunohistochemical data from the Human Protein Atlas was used to evaluate the expression of IGF2BP1 and METTL14 at the protein level and the differential expressions were also confirmed, which was consistent with the results of the TCGA-CESC datasets and 2 GEO datasets (GSE52903 and GSE44001) (Supplementary Fig. 2C, D, Supplemental Digital Content, http://links.lww.com/MD/G836). The gene discussed is IGF2BP1; the disease is cervical squamous cell carcinoma.